AND ANOTHER NEW POM FOR ANTI-WRINKLE HEADING OUR WAY
Hot on the heels of yesterday’s news that Revance Therapeutics is moving forward with trials of a product currently called DAXI, medical aesthetic company Evolus Inc has announced that the European Commission (EC) has approved the marketing of Nuceiva prabotulinumtoxinA (branded Jeuveau in the US and known in other markets as Nabota). The marketing has…